Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ultra-high-field MR imaging in multiple sclerosis.
Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis.
[Multiple sclerosis].
Commentary: Never Underestimate the Power of Adenosine in Multiple Sclerosis.
A nine-year population-based cohort study on the risk of multiple sclerosis in patients with optic neuritis.
Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling.
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.
Targeting two-pore domain potassium channels - A promising strategy for treating T cell mediated autoimmunity.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Role of puberty in multiple sclerosis risk and course.
Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.
Comparative Effects of Human Neural Stem Cells and Oligodendrocyte Progenitor Cells on the Neurobehavioral Disorders of Experimental Autoimmune Encephalomyelitis Mice.
LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS.
Correction: multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
The use of valproic acid and multiple sclerosis.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
Immunopathology of multiple sclerosis.
Celiac disease with cerebral and peripheral nerve involvement mimicking multiple sclerosis.
Reliability of the Swedish version of the Exercise Self-Efficacy Scale (S-ESES): a test-retest study in adults with neurological disease.
Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet.
Pages
« first
‹ previous
…
504
505
506
507
508
509
510
511
512
…
next ›
last »